Recovery from fixed-dose midazolam-induced anaesthesia and antagonism with flumazenil for outpatient arthroscopy.
This study evaluated recovery after a fixed dose of midazolam as induction agent and the influence of flumazenil on recovery parameters in patients undergoing day-case surgery (arthroscopy of the knee). In 40 unpremedicated patients, anaesthesia was induced with midazolam 0.2 mg/kg, vecuronium bromide 0.1 mg/kg intravenously and 3 vol.% isoflurane in oxygen prior to intubation. Anaesthesia was maintained with nitrous oxide 66% in oxygen and 0.9 vol.% isoflurane. Ten minutes after the end of anaesthesia 20 patients received 0.2 mg flumazenil intravenously, followed by increments of 0.1 mg at 60 s intervals until eye opening. Recovery was assessed by the time to eye-opening, to answering five set questions correctly, and to recovering ocular balance (Maddox Wing test), and by comparing pre- and postoperative performance in a pencil and paper test (the p-deletion test). With the exception of ocular balance, all parameters showed a quicker improvement without side-effects in the flumazenil group. After 4 h all patients were fit for discharge. One month after the procedure, all patients were satisfied with the anaesthesia. Full recovery took on average 1.5 days (range between 0 h-10 days). Whilst the technique employing a fixed dose of midazolam as induction agent gives satisfactory intraoperative anaesthesia for day-case arthroscopy, further improvement can be made with the use of flumazenil which hastens recovery.
Zuurmond
W W
WW
Department of Anaesthesiology, University of Amsterdam, The Netherlands.
van Leeuwen
L
L
Helmers
J H
JH
D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D000762:Anesthesia Recovery Period; D000777:Anesthetics; D001182:Arthroscopy; D002986:Clinical Trials as Topic; D005442:Flumazenil / Q000494:pharmacology*; D006801:Humans; D008874:Midazolam / Q000037:antagonists & inhibitors; D008875:Middle Aged; D011897:Random Allocation
D000777:Anesthetics; D005442:Flumazenil; D008874:Midazolam